REBECCA REED: Open Payments
NPI 1053797258 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 30 payments from 13 companies in 2025. Trend: 2023 $1,087 · 2024 $783 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $135 |
| Amgen Inc. | 4 | $64 |
| Abbott Laboratories | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Boston Scientific Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: DUPIXENT, Ozempic, Wegovy, FREESTYLE LIBRE 3, REPATHA, CAPLYTA, Rybelsus, WATCHMAN Access System.
Industry payments across IL — which companies pay providers there.
